Introduction The treatment landscape of hepatocellular carcinoma (HCC) has significantly
changed over the last 5 years with multiple options in the frontline, second line, and beyond …

Hepatocellular carcinoma (HCC) is usually diagnosed in an advanced stage and has
become the second deadliest type of cancer worldwide. The systemic treatment of advanced …

Hepatocellular carcinoma (HCC) is an important cause of cancer death and is considered
the 3rd most lethal around the world. Hepatectomy, liver transplantation, and ablation …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a high
mortality rate. It is regarded as a significant public health issue because of its complicated …

Hepatocellular carcinoma (HCC) is the most common type of primary hepatic cancer and is
among the major causes of mortality due to cancer. Due to the lack of efficient conventional …

Sorafenib is an oral multikinase inhibitor approved by the US Food and Drug Administration
for treatment of the patients with surgically unresectable hepatocellular carcinoma (HCC) …

Hepatocellular carcinoma (HCC) is one of the most lethal tumors in the world. Liver
resection (LR) and liver transplantation (LT) are widely considered as radical treatments for …

Background The effects of postoperative adjuvant therapy for high-risk recurrent
hepatocellular carcinoma (HCC) in immunotherapy are still under investigation. This study …

Background Hypoxia plays a crucial role in immunotherapy of hepatocellular carcinoma
(HCC) by changing the tumor microenvironment. Until now the association between hypoxia …

The efficacy and safety of CT-Guided Iodine-125 Radioactive Seed Implantation (RSI) for the
treatment of intrahepatic recurrent hepatocellular carcinoma (rHCC) were analyzed in this …